NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 1-Year …

Jan 8, 2025 · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $27.53 and …

CouponFollow Extension

$27.53
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 1-Year …

3 weeks from now

Jan 8, 2025 · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $27.53 and …

marketbeat.com

28%
OFF

NewAmsterdam Pharma Company N.V. (NAMS) - Stock Analysis

3 weeks from now

Jan 24, 2025 · Financial Performance. In 2023, NAMS's revenue was $14.09 million, a decrease of -86.28% compared to the previous year's $102.69 million. Losses were -$176.94 million, …

stockanalysis.com

$0.26
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Now Covered By …

3 weeks from now

Dec 30, 2024 · Check Out Our Latest Report on NewAmsterdam Pharma. NewAmsterdam Pharma Price Performance. Shares of NASDAQ:NAMS traded down $0.26 during trading on …

marketbeat.com

$23.37
OFF

NewAmsterdam Pharma - NAMS - Stock Price & News | The …

3 weeks from now

Real time NewAmsterdam Pharma (NAMS) stock price quote, stock graph, news & analysis. ... NewAmsterdam Pharma (NASDAQ: NAMS) $23.37 ... -$0.33. Price as of January 22, 2025, …

fool.com

$39.83
OFF

Where NewAmsterdam Pharma Stands With Analysts - Nasdaq

3 weeks from now

Dec 30, 2024 · In the assessment of 12-month price targets, analysts unveil insights for NewAmsterdam Pharma, presenting an average target of $39.83, a high estimate of $48.00, …

nasdaq.com

$23.37
OFF

Analysts Set NewAmsterdam Pharma (NASDAQ:NAMS) Price …

3 weeks from now

Jan 23, 2025 · NAMS opened at $23.37 on Monday. The company’s 50-day moving average is $23.61 and its 200 day moving average is $19.89. NewAmsterdam Pharma has a fifty-two …

etfdailynews.com

$481
OFF

NewAmsterdam Pharma: Cholesterol Drug Treatment With …

3 weeks from now

Jul 5, 2024 · NewAmsterdam Pharma Company had cash of $481.1 million as of March 31, 2024. Read why I feel NAMS is an interesting biotech stock to look into.

seekingalpha.com

$20.78
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Bought By

3 weeks from now

4 days ago · NewAmsterdam Pharma Stock Performance. NAMS stock opened at $20.78 on Thursday. NewAmsterdam Pharma has a 1-year low of $15.19 and a 1-year high of $27.29. …

marketbeat.com

$2
OFF

NewAmsterdam Pharma's SWOT Analysis: Obicetrapib Stock Shows …

3 weeks from now

5 days ago · NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion focused on developing cardiovascular …

investing.com

89%
OFF

Analysts Set NewAmsterdam Pharma (NASDAQ:NAMS) Price

3 weeks from now

Dec 26, 2024 · Finally, XTX Topco Ltd acquired a new position in shares of NewAmsterdam Pharma during the third quarter valued at about $187,000. 89.89% of the stock is owned by …

marketbeat.com

1%
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 4.1

3 weeks from now

2 days ago · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) traded up 4.1% during mid-day trading on Friday . The company traded as high as $23.24 and last traded at $22.67. …

marketbeat.com

$14.09
OFF

NewAmsterdam Pharma (NAMS) Earnings Date And Reports 2025

3 weeks from now

How to Play New Options Trading With Bitcoin ETFs; ... NewAmsterdam Pharma (NASDAQ:NAMS) has a recorded annual revenue of $14.09 million. How much profit does …

marketbeat.com

FAQs about NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 1-Year … Coupon?

Is newamsterdam Pharma (NAMS) a great growth stock in 2023?

NewAmsterdam Pharma's stock was trading at $10.90 on January 1st, 2023. Since then, NAMS stock has increased by 31.9% and is now trading at $14.38. View the best growth stocks for 2023 here. When is NewAmsterdam Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, June 30th 2023. ...

What are the target prices for newamsterdam pharma's stock?

4 equities research analysts have issued 12 month target prices for NewAmsterdam Pharma's stock. Their NAMS share price forecasts range from $19.00 to $24.00. On average, they predict the company's share price to reach $21.67 in the next year. This suggests a possible upside of 50.7% from the stock's current price. ...

How many shares in newamsterdam pharma company NV?

(0.57 (1.61 (1.55 Basic and diluted weighted average number of ordinary shares outstanding 94,754,140 82,466,584 92,666,874 82,058,225 NewAmsterdam Pharma Company N.V. Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) (In thousands of USD, except share amounts) ...

Who is newamsterdam Pharma?

NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Return vs Industry: NAMS exceeded the US Biotechs industry which returned 8.2% over the past year. ...

Is newamsterdam Pharma (NAMS) a good biotech?

Learn More » NewAmsterdam Pharma Company N.V. ( NASDAQ: NAMS) is a biotech that should be on all traders and investors' radar. The reason why I state that is because it is gearing up to report data from several studies over the next 1-year period. ...

How much cash does newamsterdam Pharma have?

According to the 10-Q SEC Filing, NewAmsterdam Pharma Company N.V. had cash of $481.1 million as of March 31, 2024. The reason for the cash on hand is because of an upsized public offering of 5,871,909 ordinary shares of its common stock and 4,736,841 pre-funded warrants. ...